ArticleSensors (Basel, Switzerland)2025
Albendazole Detection at a Nanomolar Level Through a Fabry-Pérot Interferometer Realized via Molecularly Imprinted Polymers.
Article in Sensors (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Albendazole (ABZ) is a broad-spectrum anthelmintic drug whose residual presence in food and the environment raises public health concerns, requiring rapid and sensitive methods of detection. In this work, a sensitive Fabry-Pérot interferometer (FPI) probe was fabricated by realizing a cavity located at the tip of a single-mode optical fiber core with a molecularly imprinted polymer (MIP) for ABZ detection. The fabrication process involved the development of a photoresist-based micro-hole filled by the specific MIP via thermal polymerization. Interferometric measurements obtained using the proposed sensor system have demonstrated a limit of detection (LOD) of 27 nM, a dynamic concentration range spanning from 27 nM (LOD) to 250 nM, and a linear response at the nanomolar level (27 nM-100 nM). The selectivity test demonstrated no signal when interfering molecules were present, and the application of the sensor for ABZ quantification in a commercial pharmaceutical sample provided good recovery, in accordance with bioanalytical validation standard methods. These results demonstrate the capability of a MIP layer-based FPI probe to provide low-cost and selective optical-sensing strategies, proposing a competitive approach to traditional analytical techniques for ABZ monitoring.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.